References
- Bartlett J G. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15: 573–581
- George W L, Rolfe R D, Finegold SM C. difficile and its cytotoxin in feces of patients with antimicrobial agent associated diarrhea and miscellaneous conditions. J Clin Microbiol 1982; 15: 1049–1053
- Dere W H. Acute bronchitis: results of U.S. and European trials of antibiotic therapy. Am J Med 1992; 92(Suppl 6A)53S–57S
- Zeckel M L. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials. Am J Med 92; Suppl 1992; 6A: 58S–64S
- Nord C E, Grahnen A, Eckernäs S A. Effect of loracarbef on the normal oropharyngeal and intestinal microflora. Scand J Infect Dis 1991; 23: 255–260
- Anthonisen N R, Manfreda J R, Warren C PW, Hershfield E S, Harding G KM, Nelson N A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196–204
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Approved standard M2–A4. National Committee for Clinical Laboratory Standards. Villenova, Pa 1990
- Van der Waaij D. The colonization resistance of the digestive tract in experimental animals and its consequences for infection prevention, acquisition of new bacteria and the prevention of spread of bacteria between cage mates. New criteria for antimicrobial therapy, D Van der Waaij, J Verhoef. Excerpta Medica, Amsterdam, Oxford 1979; 43–52
- Vollaard E J, Clasener H AL, van Saene H KF, Muller N F. Effect on colonization resistance: an important criterion in selecting antibiotics. DICP 1990; 24: 60–66
- Chachaty E, Depitre C, Mario N, Bourneix C, Saulnier P, Corthier G, Andremont A. Presence of Clostridium difficile and antibiotic and β-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo. Antimicrob Agents Chemother 1992; 36: 2009–2013
- Therasse D G. The safety profile of loracarbef: clinical trials in respiratory, skin and urinary tract infections. Am J Med 1992; 92(Suppl 6A)20S–25S
- Nord C E, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984; 76: 99–106